Entity

Time filter

Source Type

Toyonaka, Japan

Patent
Shionogi & Co. | Date: 2015-02-20

The present invention provides, for example, a compound mentioned below as a medicament for treating or preventing the diseases induced by production, secretion or deposition of amyloid- proteins. A compound of the formula (I): wherein R


Patent
ViiV Healthcare and Shionogi & Co. | Date: 2015-04-27

The present invention features compounds that are HIV integrase inhibitors and therefore are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.


Patent
Shionogi & Co. and ViiV Healthcare | Date: 2015-04-30

The present invention is to provide a novel compound (I) shown below, having the anti-virus activity; particularly the HIV integraso inhibitory activity, and a drug containing the same, particularly an anti-HIV drug, as well as a process and an intermediate thereof. (wherein


The present invention provides novel compounds having a P2X A pharmaceutical composition having a P2X wherein


The present invention features compounds that are prodrugs of HIV integrase inhibitors and therefore are useful in the delivery of compounds for the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.

Discover hidden collaborations